第67届美国血液学会（ASH）年会将于2025年12月6日至9日在美国佛罗里达州奥兰多举行，南京维立志博生物科技股份有限公司（以下简称“维立志博”或“公司”，股票代码：9887.HK）LBL-034、LBL-076两款在研创新药的5项研究成果被大会收录，包括1篇口头报告、3篇壁报展示和1篇在线发表。点击观看视频↓LBL-034：多项研究入选，临床数据亮相大会发言摘要标题: A first-in-...
Source Link第67届美国血液学会（ASH）年会将于2025年12月6日至9日在美国佛罗里达州奥兰多举行，南京维立志博生物科技股份有限公司（以下简称“维立志博”或“公司”，股票代码：9887.HK）LBL-034、LBL-076两款在研创新药的5项研究成果被大会收录，包括1篇口头报告、3篇壁报展示和1篇在线发表。点击观看视频↓LBL-034：多项研究入选，临床数据亮相大会发言摘要标题: A first-in-...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.